Breaking News, Financial News

Financial Report: GlaxoSmithKline

Vaccines sales drop 19% in 2011

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

GlaxoSmithKline 4Q Revenues: $10.8 billion (-2%) 4Q Earnings: $2.0 billion (loss of $979.0 million 4Q10) FY Revenues: $42.3 billion (-3%) FY Earnings: $8.4 billion (earnings were $2.9 billion FY10) Comments: Pharmaceutical sales were flat at $7.6 billion in the quarter and down 1% to $28.9 billion for the year. Vaccines sales were $1.3 billion in the quarter (-18%) and $5.4 billion for the year (-19%). Sales of pandemic related products, Avandia and Valtrex fell from $3.5 billion in 2010 to...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters